Aligos Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
3.73 |
1.87 |
4.25 |
4.90 |
136.00 |
284.25 |
| Przychód Δ r/r |
0.00% |
-50.00% |
127.68% |
15.29% |
2675.58% |
109.00% |
| Przychód (min) |
3.31 |
1.37 |
3.12 |
3.60 |
99.88 |
208.74 |
| Przychód (max) |
4.58 |
2.54 |
5.79 |
6.68 |
185.34 |
387.37 |
| EBITDA (średnia) |
-2.24 |
-1.12 |
-2.55 |
-2.94 |
-81.60 |
-170.55 |
| EBIT (średnia) |
-2.24 |
-1.12 |
-2.55 |
-2.94 |
-81.60 |
-170.55 |
| EBIT % |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
-60.00% |
| Zysk netto (średni) |
-63.23 |
-60.75 |
-55.71 |
-56.60 |
8.46 |
95.22 |
| Zysk netto % |
-1693.68% |
-3254.24% |
-1310.90% |
-1155.12% |
6.22% |
33.50% |
| EPS (średnia) |
-10.09 |
-9.70 |
-8.89 |
-9.04 |
1.35 |
15.20 |
| Liczba analityków (Przychody) |
3 |
2 |
3 |
2 |
1 |
1 |
| Liczba analityków (EPS) |
2 |
2 |
2 |
2 |
1 |
1 |
| symbol |
ALGS |
ALGS |
ALGS |
ALGS |
ALGS |
ALGS |